Author:
Seufferlein Thomas,Mayerle Julia
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Hepatology
Reference10 articles.
1. Rahib, L. et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 74, 2913–2921 (2014).
2. Gui, J. C. et al. CA19-9 and CA242 as tumor markers for the diagnosis of pancreatic cancer: a meta-analysis. Clin. Exp. Med. 14, 225–233 (2014).
3. Poruk, K. E. et al. The clinical utility of CA 19–9 in pancreatic adenocarcinoma: diagnostic and prognostic updates. Curr. Mol. Med. 13, 340–351 (2013).
4. Ghatnekar, O. et al. Modelling the benefits of early diagnosis of pancreatic cancer using a biomarker signature. Int. J. Cancer 133, 2392–2397 (2013).
5. Melo, S. A. et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature 523, 177–182 (2015).
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献